Back
Tectonic Therapeutic Vs. EyePoint Pharmaceuticals Industry Stock Comparison
Buy
85
TECX
Tectonic Therapeutic
Last Price:
32.94
Seasonality Move:
-12.36%
Sell
50
EYPT
EyePoint Pharmaceuticals
Last Price:
8.65
Seasonality Move:
-4.78%
Buy
85
Tectonic Therapeutic (TECX)
is a Buy
Is Tectonic Therapeutic a Buy, Sell or Hold?
- The current Tectonic Therapeutic [TECX] share price is $33.02. The Score for TECX is 85, which is 70% above its historic median score of 50, and infers lower risk than normal.
- TECX is currently trading in the 80-90% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk levels may be considerably lower than normal.
Sell
50
EyePoint Pharmaceuticals (EYPT)
is a Sell
Is EyePoint Pharmaceuticals a Buy, Sell or Hold?
- The current EyePoint Pharmaceuticals [EYPT] share price is $8.63. The Score for EYPT is 50, which is 0% below its historic median score of 50, and infers higher risk than normal.
- EYPT is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
TECX Stock Price Chart
What is Tectonic Therapeutic's stock price today?
-
The Tectonic Therapeutic share price today is $33.02
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and TECX is experiencing buying pressure, which is a positive indicator for future bullish movement.
EYPT Stock Price Chart
What is EyePoint Pharmaceuticals's stock price today?
-
The EyePoint Pharmaceuticals share price today is $8.63
The current trend is relatively stagnant and EYPT is experiencing buying pressure, which is a positive indicator for future bullish movement.
TECX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 3.49 | Buy |
| Relative Strength Index (14 RSI): | 79.13 | Buy |
| Chaikin Money Flow: | 201646 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (17.2 - 27.82) | Buy |
| Bollinger Bands (100): | (14.73 - 22.01) | Buy |
EYPT Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.1 | Sell |
| Relative Strength Index (14 RSI): | 53.06 | Buy |
| Chaikin Money Flow: | 175844 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (8.04 - 8.82) | Buy |
| Bollinger Bands (100): | (8.03 - 10.31) | Sell |
TECX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 29.91 | Buy |
| 20-day SMA: | 23.43 | Buy |
| 50-day SMA: | 19.89 | Buy |
| 200-day SMA: | 16.98 | Buy |
| 8-day EMA: | 29.07 | Buy |
| 20-day EMA: | 25.2 | Buy |
| 50-day EMA: | 21.37 | Buy |
| 200-day EMA: | 17.83 | Buy |
EYPT Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 8.18 | Buy |
| 20-day SMA: | 8.46 | Buy |
| 50-day SMA: | 8.6 | Buy |
| 200-day SMA: | 15.81 | Sell |
| 8-day EMA: | 8.33 | Buy |
| 20-day EMA: | 8.4 | Buy |
| 50-day EMA: | 8.79 | Sell |
| 200-day EMA: | 11.92 | Sell |
Tectonic Therapeutic Earnings Growth & TECX Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
EyePoint Pharmaceuticals Earnings Growth & EYPT Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.21 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.42 per share, and a decrease next year of $0.94 per share.
Tectonic Therapeutic Technical Analysis
| Sep 23 | Sep 24 | Sep 25 | Sep 26 | Sep 27 | Sep 30 | Oct 1 | Oct 2 | Oct 3 | Oct 4 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | Oct | |||||||||
| 23 | 24 | 25 | 26 | 27 | 30 | 01 | 02 | 03 | 04 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
EyePoint Pharmaceuticals Technical Analysis
| Sep 23 | Sep 24 | Sep 25 | Sep 26 | Sep 27 | Sep 30 | Oct 1 | Oct 2 | Oct 3 | Oct 4 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | Oct | |||||||||
| 23 | 24 | 25 | 26 | 27 | 30 | 01 | 02 | 03 | 04 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||